Literature DB >> 7874944

Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies.

D E Sassi-Dambron1, E G Eakin, A L Ries, R M Kaplan.   

Abstract

We conducted a randomized clinical trial to evaluate a limited pulmonary rehabilitation program focused on coping strategies for shortness of breath but without exercise training. Eighty-nine patients with COPD were randomly assigned to either 6-week treatment or general health education control groups. Treatment consisted of instruction and practice in techniques of progressive muscle relaxation, breathing retraining, pacing, self-talk, and panic control. Tests of 6-min walk distance, quality of well-being, and psychological function as well as six dyspnea measures were administered at baseline, posttreatment, and 6 months after the intervention. Baseline pulmonary function tests also were obtained. At the end of the 6-week treatment, there were no significant differences between the treatment and control groups on any outcome measure. At the 6-month follow-up, a significant group difference was seen on only one variable, Mahler's transition dyspnea index. The results of this evaluation suggest that a treatment program of dyspnea management strategies, without structured exercise training or other components of a comprehensive pulmonary rehabilitation program, is not sufficient to produce significant improvement in dyspnea, exercise tolerance, health-related quality of well-being, anxiety, or depression.

Entities:  

Mesh:

Year:  1995        PMID: 7874944     DOI: 10.1378/chest.107.3.724

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Dysfunctional breathing in asthma: is it common, identifiable and correctable?

Authors:  M D L Morgan
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Patients' self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries; D E Sassi-Dambron
Journal:  Ann Behav Med       Date:  1996-06

3.  Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.

Authors:  Marc B Feinstein; Paul Krebs; Elliot J Coups; Bernard J Park; Richard M Steingart; Jack Burkhalter; Amy Logue; Jamie S Ostroff
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

Review 4.  Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shu-Yi Liao; Roberto Benzo; Andrew L Ries; Xavier Soler
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

5.  Reliability and validity of dyspnea measures in patients with obstructive lung disease.

Authors:  E G Eakin; D E Sassi-Dambron; A L Ries; R M Kaplan
Journal:  Int J Behav Med       Date:  1995

6.  Outcome measurement for COPD: reliability and validity of the Dyspnea Management Questionnaire.

Authors:  Anna Norweg; Alan M Jette; Pengsheng Ni; Jonathan Whiteson; Minjin Kim
Journal:  Respir Med       Date:  2010-09-29       Impact factor: 3.415

7.  Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials.

Authors:  Ghassan F Salman; Michael C Mosier; Brent W Beasley; David R Calkins
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

Review 8.  Focusing on outcomes: making the most of COPD interventions.

Authors:  Noreen M Clark; Julia A Dodge; Martyn R Partridge; Fernando J Martinez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

Review 9.  Self-management education for patients with chronic obstructive pulmonary disease: a systematic review.

Authors:  E Monninkhof; P van der Valk; J van der Palen; C van Herwaarden; M R Partridge; G Zielhuis
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

10.  Effect of a noninvasive ventilatory support during exercise of a program in pulmonary rehabilitation in patients with COPD.

Authors:  Shahin Barakat; Germain Michele; Pascale Nesme; Viallet Nicole; Annat Guy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.